1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Restless Legs Syndrome Global Clinical Trials Review, H1, 2014

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restless Legs Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Restless Legs Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Restless Legs Syndrome 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Restless Legs Syndrome Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
C. H. Boehringer Sohn AG and Co. KG 33
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 33
UCB S.A. 36
Clinical Trial Overview of UCB S.A. 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
XenoPort, Inc. 40
Clinical Trial Overview of XenoPort, Inc. 40
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Otsuka Holdings Co., Ltd. 42
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42
Impax Laboratories, Inc. 43
Clinical Trial Overview of Impax Laboratories, Inc. 43
Daiichi Sankyo Company, Limited 44
Clinical Trial Overview of Daiichi Sankyo Company, Limited 44
Astellas Pharma Inc. 45
Clinical Trial Overview of Astellas Pharma Inc. 45
Boehringer Ingelheim Auslandsbeteiligungs GmbH 46
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 46
Clinical Trial Overview of Top Institutes / Government 47
National Institute of Neurological Disorders and Stroke 47
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 47
Brigham and Women's Hospital 48
Clinical Trial Overview of Brigham and Women's Hospital 48
Johns Hopkins University 49
Clinical Trial Overview of Johns Hopkins University 49
Massachusetts General Hospital 50
Clinical Trial Overview of Massachusetts General Hospital 50
University of South Florida 51
Clinical Trial Overview of University of South Florida 51
Instituto de Investigaciones del Sueno 52
Clinical Trial Overview of Instituto de Investigaciones del Sueno 52
Nanjing Medical University 53
Clinical Trial Overview of Nanjing Medical University 53
Children's Hospitals and Clinics of Minnesota 54
Clinical Trial Overview of Children's Hospitals and Clinics of Minnesota 54
University Hospital, Bordeaux 55
Clinical Trial Overview of University Hospital, Bordeaux 55
National Institute on Aging 56
Clinical Trial Overview of National Institute on Aging 56
Five Key Clinical Profiles 57
Appendix 147
Abbreviations 147
Definitions 147
Research Methodology 148
Secondary Research 148
About GlobalData 149
Contact Us 149
Disclaimer 149
Source 149

List of Tables
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region, 2014* 7
Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Restless Legs Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Restless Legs Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Restless Legs Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 33
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 36
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by XenoPort, Inc., 2014* 40
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 41
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 42
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Impax Laboratories, Inc., 2014* 43
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 44
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 45
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 46
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 47
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 48
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 49
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 50
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 51
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto de Investigaciones del Sueno, 2014* 52
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014* 53
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospitals and Clinics of Minnesota, 2014* 54
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 55
Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 56

List of Figures
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 148

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Related Market Segments :

Therapy
Clinical Trial
Neurological Disorder

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.